Patent Assignment
Reel/Frame 025493/0683
Merger
Recorded: 2010-12-13
Pages: 8
Assignor
CENTELION
Executed: 2009-12-31
Assignee
AVENTIS PHARMA S.A.
20 AVENUE RAYMOND ARON, ANTONY, 92160, FRANCE
Covered Properties
(5)
Adenovirus Vectors and Method for Reducing Homologous Recombination Phenomena
Patent:
6,410,298 →
Application:
09/530,378 →
Treatment of hypercholesterolemia or diabetes associated angiogenic defects
Application:
10/861,906 →
Publication:
US 2005/0096286
Method of preparation for pharmaceutical grade plasmid DNA
Application:
11/384,191 →
Publication:
US 2007/0111221
Anti-vascular and anti-proliferation methods, therapies, and combinations employing specific tyrosine kinase inhibitors
Application:
11/519,935 →
Publication:
US 2007/0197538
Method for purifying plasmid DNA
Application:
11/582,427 →
Publication:
US 2007/0213289
Related Assignments
(8)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name
Mar 15, 2001
From: CROUZET, JOEL; ROBERT, JEAN-JACQUES; VIGNE, EMMANUELLE; YEH, PATRICE
To: AVENTIS PHARMA S.A.
Reel/Frame 011604/0648 →
Change of Name
Jun 7, 2001
From: RHONE-POULENC RORER S.A.
To: AVENTIS PHARMA S.A.
Reel/Frame 011641/0962 →
Assignment of Assignor's Interest
Feb 20, 2002
From: CROUZET, JOEL; ROBERT, JEAN-JACQUES; VIGNE, EMMANUELLE; YEH, PATRICE
To: AVENTIS PHARMA S.A.
Reel/Frame 012602/0824 →
Change of Name
Jan 5, 2005
From: GENCELL S.A.
To: GENCELL S.A.S.
Reel/Frame 015530/0338 →
Change of Name
Jan 6, 2005
From: GENCELL S.A.S.
To: CENTELION
Reel/Frame 015541/0986 →
Assignment of Assignor's Interest
Jan 13, 2005
From: AVENTIS PHARMA S.A.
To: GENCELL S.A.
Reel/Frame 015592/0978 →
Assignment of Assignor's Interest
Feb 17, 2005
From: CARON, ALEXIS; EMMANUEL, FLORENCE; FINIELS, FRANCOISE; MICHELET, SANDRINE
To: CENTELION SAS
Reel/Frame 015735/0678 →
Assignment of Assignor's Interest
Feb 15, 2007
From: BLANCHE, FRANCIS; COUDER, MICHEL; MAESTRALI, NICOLAS; GUILLEMIN, THIERRY
To: CENTELION
Reel/Frame 019090/0960 →